Why the study?
Does Tai Chi Chuan training improve autonomic responses and rate pressure product in practitioners compared to non-trained sedentary controls?
Does Tai Chi Chuan training improve autonomic responses and rate pressure product in practitioners compared to non-trained sedentary controls?
Tai Chi practitioners demonstrate more cardioprotective autonomic responses and lower rate pressure product compared to sedentary controls, suggesting potential benefits as an adjunct to non-pharmacological anti-hypertensive therapy.
Tai Chi practice was associated with favorable autonomic and hemodynamic profiles; hypothesis-generating and should not yet change practice.
BACKGROUND: Spectral analysis of autonomic nervous system activity can provide insight into cardiovascular function. Rate pressure product is the parameter often targeted pharmacologically to decrease the incidence of myocardial events. AIM: The purpose of this study was to investigate whether or not Tai Chi Chuan practitioners would demonstrate autonomic responses that would be more cardioprotective when compared to non-trained controls. MATERIALS AND METHODS: This was a cross-sectional study that measured the autonomic responses and rate pressure product of 2 groups of subjects; a Tai Chi Chuan trained (n = 13) and non-trained sedentary controls (n = 13) at rest and during 2 stressor phases that simulated functional activities of daily living. RESULTS: The Tai Chi group maintained a greater parasympathetic outflow at rest and during the isometric grip stressor phase (P<0.05). Sympathetic outflow, systolic blood pressure and rate pressure product were significantly lower in the Tai Chi group at rest, during the isometric grip and standing stressor phases (P<0.05). CONCLUSION: Although a cause-and-effect relationship cannot be concluded in this study, the Tai Chi group was able to demonstrate efficiency of the myocardium with suppressed rate pressure product values and autonomic responses that favored parasympathetic outflow. This type of training may complement non-pharmacological anti-hypertensive therapy.
No takes yet. Share an insight, caveat, or question.
Figueroa et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: